Provided by Tiger Trade Technology Pte. Ltd.

Agree

72.58
+0.07500.10%
Volume:548.17K
Turnover:39.68M
Market Cap:9.03B
PE:39.19
High:72.95
Open:72.80
Low:71.85
Close:72.50
52wk High:82.08
52wk Low:69.56
Shares:124.38M
Float Shares:122.18M
Volume Ratio:0.72
T/O Rate:0.45%
Dividend:3.14
Dividend Rate:4.33%
EPS(TTM):1.85
EPS(LYR):1.77
ROE:3.70%
ROA:2.40%
PB:1.42
PE(LYR):41.00

Loading ...

South Bow Units Agree to Pay Over $26 Million to Settle Keystone Pipeline Spill Claims

MT Newswires Live
·
Jul 10

BIOCYTOGEN-B Shares Surge Over 14% Following Strategic Global Partnership Announcement for BsADC Development

Stock News
·
Jul 10

Daiichi Sankyo’s Pediatric Cancer Trial Adds Quiet Momentum to Its ADC Pipeline

TIPRANKS
·
Jul 09

VERAXA Biotech (NASDAQ: VRXA) Shareholders Should Watch Novartis Latest $1.5B ADC Acquisition

TIPRANKS
·
Jul 08

Canada, Turkey Agree to Talks Toward Possible Free-trade Treaty

Dow Jones
·
Jul 07

What Did Prabowo, Modi Agree on Higher Education?

Tempo
·
Jul 07

Indonesia, India Agree to Develop Ports Linking Sabang-Andaman

Tempo
·
Jul 07

Indonesia, Singapore Agree to Build Joint Military Training Facilities

Tempo
·
Jul 07

Analysts Offer Insights on Real Estate Companies: Alexandria Equities (ARE) and Agree Realty (ADC)

TIPRANKS
·
Jul 07

Patent cliff fuels Novartis’ $1.5bn swoop for London biotech

cityam
·
Jul 07

Press Release: Corbus Pharmaceuticals Appoints Leonardo Viana Nicacio, M.D. as Chief Medical Officer

Dow Jones
·
Jul 06

ArriVent’s Emerging CDH17-Targeted ADC Pipeline Supports Maintained Buy Rating and $45 Price Target

TIPRANKS
·
Jul 06

Prabowo, Wong Agree to Keep Malacca Strait Open

Tempo
·
Jul 06

Two Banks Agreed to Merge. They Can't Agree on How to Make Chili.

Dow Jones
·
Jul 06

Novartis Bolsters Oncology Pipeline with $1.5 Billion Acquisition of Myricx Bio

Stock News
·
Jul 06

Novartis agrees to acquire Myricx Bio, advancing next-generation antibody-drug conjugate innovation with a novel NMTi payload, expanding options for cancer patients

GlobeNewswire
·
Jul 06

Innocare's Stock Surges Over 9% as First Patient Dosed with Novel In-house Developed CDH17-Targeting ADC Drug

Deep News
·
Jul 06

Innocare Shares Surge Over 8% Following First Patient Dosing of Novel In-House ADC Drug

Stock News
·
Jul 06

Oil Prices Fall as OPEC, Allies Agree to Hike Output

Dow Jones
·
Jul 06

InnoCare Announces First Patient Dosed in Clinical Trial of Novel CDH17 targeted ADC ICP-B208 in China

GlobeNewswire
·
Jul 06